Mackenzie Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.1M | Buy |
208,409
+189,412
| +997% | +$20.1M | 0.03% | 348 |
|
2025
Q1 | $2.36M | Sell |
18,997
-1,289
| -6% | -$160K | ﹤0.01% | 737 |
|
2024
Q4 | $2.5M | Buy |
20,286
+16,867
| +493% | +$2.08M | ﹤0.01% | 712 |
|
2024
Q3 | $381K | Buy |
3,419
+120
| +4% | +$13.4K | ﹤0.01% | 1092 |
|
2024
Q2 | $352K | Sell |
3,299
-29,211
| -90% | -$3.12M | ﹤0.01% | 1105 |
|
2024
Q1 | $3.91M | Sell |
32,510
-12,038
| -27% | -$1.45M | 0.01% | 593 |
|
2023
Q4 | $5.48M | Buy |
44,548
+42,675
| +2,278% | +$5.25M | 0.01% | 539 |
|
2023
Q3 | $238K | Sell |
1,873
-337
| -15% | -$42.8K | ﹤0.01% | 1220 |
|
2023
Q2 | $274K | Buy |
2,210
+145
| +7% | +$18K | ﹤0.01% | 1200 |
|
2023
Q1 | $302K | Buy |
+2,065
| New | +$302K | ﹤0.01% | 1180 |
|
2022
Q4 | – | Sell |
-11,498
| Closed | -$1.53M | – | 1510 |
|
2022
Q3 | $1.53M | Buy |
11,498
+693
| +6% | +$92.4K | ﹤0.01% | 750 |
|
2022
Q2 | $1.69M | Buy |
+10,805
| New | +$1.69M | ﹤0.01% | 755 |
|
2021
Q4 | – | Sell |
-12,702
| Closed | -$1.65M | – | 1468 |
|
2021
Q3 | $1.65M | Sell |
12,702
-1,245
| -9% | -$162K | ﹤0.01% | 789 |
|
2021
Q2 | $2.48M | Sell |
13,947
-2,131
| -13% | -$379K | ﹤0.01% | 681 |
|
2021
Q1 | $2.64M | Sell |
16,078
-21,932
| -58% | -$3.61M | ﹤0.01% | 635 |
|
2020
Q4 | $6.27M | Sell |
38,010
-1,428
| -4% | -$236K | 0.01% | 409 |
|
2020
Q3 | $5.62M | Sell |
39,438
-2,804
| -7% | -$400K | 0.01% | 386 |
|
2020
Q2 | $4.66M | Buy |
42,242
+23,608
| +127% | +$2.6M | 0.01% | 409 |
|
2020
Q1 | $1.86M | Buy |
18,634
+2,566
| +16% | +$256K | 0.01% | 515 |
|
2019
Q4 | $2.4M | Buy |
16,068
+2,050
| +15% | +$306K | 0.01% | 579 |
|
2019
Q3 | $1.8M | Sell |
14,018
-2,546
| -15% | -$326K | ﹤0.01% | 625 |
|
2019
Q2 | $2.36M | Buy |
16,564
+1,229
| +8% | +$175K | 0.01% | 594 |
|
2019
Q1 | $2.19M | Sell |
15,335
-15,240
| -50% | -$2.18M | 0.01% | 763 |
|
2018
Q4 | $3.79M | Buy |
30,575
+24,102
| +372% | +$2.99M | 0.01% | 573 |
|
2018
Q3 | $1.09M | Buy |
6,473
+112
| +2% | +$18.8K | ﹤0.01% | 742 |
|
2018
Q2 | $1.1M | Buy |
6,361
+219
| +4% | +$37.7K | ﹤0.01% | 673 |
|
2018
Q1 | $927K | Buy |
6,142
+91
| +2% | +$13.7K | ﹤0.01% | 647 |
|
2017
Q4 | $815K | Buy |
+6,051
| New | +$815K | ﹤0.01% | 621 |
|
2016
Q4 | – | Sell |
-2,228
| Closed | -$271K | – | 685 |
|
2016
Q3 | $271K | Sell |
2,228
-13,000
| -85% | -$1.58M | ﹤0.01% | 576 |
|
2016
Q2 | $2.15M | Sell |
15,228
-4,700
| -24% | -$664K | 0.01% | 422 |
|
2016
Q1 | $2.6M | Buy |
19,928
+3,328
| +20% | +$435K | 0.02% | 316 |
|
2015
Q4 | $2.33M | Buy |
16,600
+1,321
| +9% | +$186K | 0.01% | 388 |
|
2015
Q3 | $2.03M | Buy |
15,279
+1,300
| +9% | +$173K | 0.01% | 406 |
|
2015
Q2 | $2.46M | Buy |
13,979
+579
| +4% | +$102K | 0.01% | 396 |
|
2015
Q1 | $2.32M | Buy |
13,400
+1,800
| +16% | +$311K | 0.01% | 395 |
|
2014
Q4 | $1.9M | Buy |
11,600
+300
| +3% | +$49.1K | 0.01% | 421 |
|
2014
Q3 | $1.81M | Buy |
+11,300
| New | +$1.81M | 0.01% | 404 |
|